Hebei Kaiwei Hengcheng Pharmaceutical Co., Ltd.(abbreviated as Kaiweihengcheng), established in 2020, is headquartered in Zhangjiakou City, Hebei Province. It owns Hainan Hengcheng Pharmaceutical Technology Co., Ltd. and Zhangjiakou Aibino Pharmaceutical Technology Co., Ltd., and is a high-tech enterprise integrating drug R&D, sales, and promotion.
 The company currently holds 36 drug approval numbers, 23 trademarks, and 14 patents, demonstrating a solid industrial foundation and sustained R&D capabilities. Since its establishment, Kaivihengcheng has been repeatedly honored with accolades, including recognition as a "National-level Technology-based SME," "National High-tech Enterprise," "Grade A R&D Institution for Industrial Enterprises in Hebei Province," "Specialized and Innovative SME in Hebei Province," and "Innovative SME." Additionally, the company has established the "Zhangjiakou Enterprise Technology Center" and the "Zhangjiakou Technology Innovation Center," further refining its innovation system.